Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Martek signs sole source supply agreement with Grupo Ricap
Grupo Ricap is a third-party manufacturer of infant formula and Martek’s life’sDHA & life’sARA will initially be available in infant formula products produced for a large chain of
Grupo Ricap is a third-party manufacturer of infant formula and Martek’s life’sDHA & life’sARA will initially be available in infant formula products produced for a large chain of
These clinical trials, known collectively as the Fame study, consist of two double masked, randomized, multi-center trials that are following 956 patients in the US, Canada, Europe and
Receiving the 510(k) enables I-Flow to start on the path to clinical studies on the dressing in keeping with a plan to make the product commercially available in
Health Canada and the FDA have approved the initiation of studies of CPI-613, which will be conducted at clinical trial sites in both the US and Canada. The
Under the terms of the agreement, Genzyme will gain access to elements of Asterion’s IP portfolio surrounding a specific protein target and will perform research work designed to
Affitech said that it has successfully used its molecule based antibody screening system that included its proprietary antibody library and high throughput screening technology to identify several fully
According to the company, Mr Kaiser brings more than three decades of executive-level leadership to the board at a time when RBC Life Sciences is focusing on aggressive
Mr Kilvington will be responsible for scientific and managerial leadership of the company’s microbiology activities in support of the discovery and development of new products for contact lens
Pursuant to the stock purchase agreement, Nerveda will fund DioGenix with at least $5 million to accelerate and expand the company’s proprietary programs, led by blood-based tests for
The Phase I trial was a randomized, double-blind, placebo-controlled, single ascending dose study in 26 healthy volunteers who received the medication or placebo subcutaneously. The objective of the